The temperature-sensitive liposome is now in Phase I human clinical trials. This review will provide an update, recapping earlier work and presenting new data that show unexpected mechanistic features that make this triggered-release system an emerging new paradigm for local drug delivery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据